16 results
8-K
EX-99.1
ESPR
Esperion Therapeutics Inc.
1 Aug 23
Esperion Reports Second Quarter 2023 Financial Results
7:07am
% and approximately 7%, respectively, primarily related to upfront training costs for our contract sales force and higher legal costs.
The Company had net losses
PRE 14A
48heam 0k0wdqt
4 Apr 22
Preliminary proxy
4:03pm
8-K
0tds978g v1uags5g9fa
28 Jun 21
ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer
4:03pm
8-K
EX-99.1
izbzj
28 Jun 21
ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer
4:03pm
8-K
EX-10.1
pdkappyz cro0sfsy2g
26 Jun 19
Esperion and Oberland Capital Announce $200 Million Funding Agreement
5:18pm
8-K
tdzgyju4 2rv
13 Jan 14
Departure of Directors or Certain Officers
12:00am
- Prev
- 1
- Next